TrialEuropean heart journal2022

Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: the SUGAR trial.

Rafael Romaguera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.